IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.

S196 The present and the future of toxins: what's new
Saturday 28 January 2023
14:00 to 15:30
Amphi Bleu - Level 2
SESIÓN ENFOCADA

Moderador(es)

Dr Benjamin ASCHER
Cirujano Plástico
Francia
Dr Philippe PICAUT
PhD - Investigación
Francia

Presentaciones de la sesión

14:00

Introduction by the chairs

14:02

Toxins overview: 2023 update

14:10

LetibotulinumtoxinA: what’s new 1 year after approval? (Croma)

14:10

Part 1 - Future botulinum toxins to arrive on the European market

14:18

Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)

14:26

DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)

14:34

Panel discussion

14:49

Part 2 - Novel botulinum toxins

14:49

How to boost your usual toxin performance? (Fastox)

14:57

RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)

15:05

ET-01 – A phase 2b topical botulinum product candidate (Eirion)

15:13

Panel discussion

Sesiones recomendadas

¿Tienes una pregunta?

Discover IMCAS Academy

Follow IMCAS

Need assistance?

Privacy policy Información legal
© 2025 IMCAS International Master Course on Aging Science. All rights reserved.

Error

Please fill out all required fields. Here are the fields that are missing: